| 111In-benzyl-DTPA–ZHER2: 342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors V Tolmachev, FY Nilsson, C Widström, K Andersson, D Rosik, L Gedda, ... Journal of Nuclear Medicine 47 (5), 846-853, 2006 | 139 | 2006 |
| Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents E Bohl Kullberg, N Bergstrand, J Carlsson, K Edwards, M Johnsson, ... Bioconjugate chemistry 13 (4), 737-743, 2002 | 132 | 2002 |
| Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with 125I-EGF H Björkelund, L Gedda, P Barta, M Malmqvist, K Andersson PLoS One 6 (9), e24739, 2011 | 91 | 2011 |
| Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules N Kronqvist, M Malm, L Göstring, E Gunneriusson, M Nilsson, ... Protein Engineering, Design & Selection 24 (4), 385-396, 2011 | 91 | 2011 |
| Engineering and characterization of a bispecific HER2× EGFR‐binding affibody molecule M Friedman, S Lindström, L Ekerljung, H Andersson‐Svahn, J Carlsson, ... Biotechnology and applied biochemistry 54 (2), 121-131, 2009 | 86 | 2009 |
| Panchromatic ternary polymer dots involving sub-picosecond energy and charge transfer for efficient and stable photocatalytic hydrogen evolution A Liu, L Gedda, M Axelsson, M Pavliuk, K Edwards, L Hammarström, ... Journal of the American Chemical Society 143 (7), 2875-2885, 2021 | 85 | 2021 |
| Ligand liposomes and boron neutron capture therapy J Carlsson, EB Kullberg, J Capala, S Sjöberg, K Edwards, L Gedda Journal of neuro-oncology 62, 47-59, 2003 | 83 | 2003 |
| Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin X Wu, A Wanders, P Wardega, B Tinge, L Gedda, S Bergstrom, L Sooman, ... British journal of cancer 100 (2), 334-343, 2009 | 82 | 2009 |
| Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy S Sjöberg, J Carlsson, H Ghaneolhosseini, L Gedda, T Hartman, ... Journal of neuro-oncology 33, 41-52, 1997 | 82 | 1997 |
| Flow cytometric in situ proximity ligation analyses of protein interactions and post‐translational modification of the epidermal growth factor receptor family KJ Leuchowius, I Weibrecht, U Landegren, L Gedda, O Söderberg Cytometry Part A: The Journal of the International Society for Advancement …, 2009 | 78 | 2009 |
| Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor J Carlsson, L Gedda, C Grönvik, T Hartman, A Lindström, P Lindström, ... International Journal of Radiation Oncology* Biology* Physics 30 (1), 105-115, 1994 | 73 | 1994 |
| Development and in vitro studies of epidermal growth factor− dextran conjugates for boron neutron capture therapy L Gedda, P Olsson, J Pontén, J Carlsson Bioconjugate chemistry 7 (5), 584-591, 1996 | 72 | 1996 |
| Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular context H Björkelund, L Gedda, K Andersson PloS one 6 (1), e16536, 2011 | 71 | 2011 |
| [177Lu]Pertuzumab: Experimental Therapy of HER-2–Expressing Xenografts M Persson, L Gedda, H Lundqvist, V Tolmachev, H Nordgren, ... Cancer research 67 (1), 326-331, 2007 | 66 | 2007 |
| [177Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells M Persson, V Tolmachev, K Andersson, L Gedda, M Sandström, ... European journal of nuclear medicine and molecular imaging 32, 1457-1462, 2005 | 63 | 2005 |
| Tumor-cell targeted epidermal growth factor liposomes loaded with boronated acridine: uptake and processing EB Kullberg, M Nestor, L Gedda Pharmaceutical research 20, 229-236, 2003 | 59 | 2003 |
| Cellular effects of HER3-specific affibody molecules L Göstring, M Malm, I Höidén-Guthenberg, FY Frejd, S Ståhl, J Löfblom, ... PloS one 7 (6), e40023, 2012 | 56 | 2012 |
| Closo-Dodecaborate(2-) as a Linker for Iodination of Macromolecules. Aspects on Conjugation Chemistry and Biodistribution V Tolmachev, J Koziorowski, I Sivaev, H Lundqvist, J Carlsson, A Orlova, ... Bioconjugate chemistry 10 (3), 338-345, 1999 | 53 | 1999 |
| Cellular processing of 125I-and 111In-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells A Orlova, A Bruskin, A Sjöström, H Lundqvist, L Gedda, V Tolmachev Nuclear medicine and biology 27 (8), 827-835, 2000 | 52 | 2000 |
| A new antibody recognizing the vIII mutation of human epidermal growth factor receptor L Öhman, L Gedda, G Hesselager, R Larsson, M Nister, T Stigbrand, ... Tumor biology 23 (2), 61-69, 2002 | 48 | 2002 |
